Statistics
Publications
2
Citations
34
H-Index
2
Active since
2019
Affiliations
Novartis (Switzerland)(Current)
Doug McLaughlin is an author at Novartis (Switzerland) specializing in medicinal chemistry, ligand binding, and matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
Publications per year
2019–2021
2
2
A small-molecule inhibitor of C5 complement protein
Keith Jendza, Mitsunori Kato, Michael Salcius et al. · Nature Chemical Biology · 2019 · 21 citations
1–2 of 2